Is the model for end-stage liver disease (MELD) score the best way to evaluate liver transplant patients preoperatively?

Benjamin Heller, Jeron Zerillo

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

A 52-year-old male with a past medical history of hepatitis C cirrhosis, hypertension, hyperlipidemia, and a body mass index of 34 presents for deceased donor liver transplantation. He has been on the liver transplant list for 6 months. His international normalized ratio (INR) is 2.1, creatinine is 1.6, and total bilirubin is 8.4, and he has never undergone renal replacement therapy. As a result, his preoperative Model for End-Stage Liver Disease (MELD) score is 27. In the holding area, he responds appropriately to most questions, although his wife reports that he has seemed more confused in the past 2 days. On physical exam, you note that the patient is diffusely jaundiced, has spider angiomas, and has marked ascites.

Original languageEnglish (US)
Title of host publicationYou're Wrong, I'm Right
Subtitle of host publicationDueling Authors Reexamine Classic Teachings in Anesthesia
PublisherSpringer International Publishing
Pages229-231
Number of pages3
ISBN (Electronic)9783319431697
ISBN (Print)9783319431673
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Keywords

  • Child-turcotte-pugh (CTP) score
  • Liver transplant anesthesiology
  • Model for end-stage liver disease (MELD) score
  • Transplant list
  • United network of organ sharing (UNOS)

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Is the model for end-stage liver disease (MELD) score the best way to evaluate liver transplant patients preoperatively?'. Together they form a unique fingerprint.

Cite this